To the Editor, Idiopathic multicentric Castleman disease (iMCD) represents a group of poorly
understood lymphoproliferative disorders with limited treatment options. 1 Despite …

A 16-year-old male patient was admitted to our hospital in March 2012 with chief complaints
of systemic lymphadenopathy for> 4 years with significant enlargement in the bilateral …

RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …

Castleman disease represents a group of rare lymphoproliferative disorders with
heterogeneous manifestations and similar histopathological features. Due to its broad …

Castleman disease is a rare B-cell lymphoproliferative disorder characterized by lymph
node enlargement with or without constitutional signs. Herein, we describe a unique patient …

Castleman disease (CD) is uncommon non-clonal lymphoproliferative disorder with
unknown etiology. No standard therapy is recommended for relapsed/refractory CD patients …

Castleman disease is a rare idiopathic non-neoplastic lymphoproliferative disorder with 2
clinical (unicentric and multicentric) and 3 histomorphological (hyaline-vascular, plasma-cell …

First described in 1954 by Dr. Benjamin Castleman as localized mediastinal lymph node
hyperplasia, Castleman disease (CD) represents a non-clonal lymphoproliferative disorder …

Castleman disease (CD) is a rare lymphoproliferative disease, involving lymphadenopathy
and constitutional inflammatory symptoms, with a variable clinical course that includes …

Relapsed and refractory (R/R) idiopathic multicentric Castleman disease (iMCD) is a clinical
challenge with no standard treatment. In this preliminary clinical trial, we investigated the …